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Pseudomonas fulva has not yet been isolated from humans as a pathogen. Herein, we report the first case of
P. fulva bacteremia in a patient hospitalized due to trauma. The species was identified using biochemical and
molecular genetic analyses of the 16S rRNA, gyrB, rpoB, and rpoD genes.
CASE REPORT
A 56-year-old man who was seriously injured in an accident
at a construction site was admitted to the emergency depart-
ment. He had emergency surgery for femur fracture and fem-
oral artery rupture and received amikacin and cefotiam on the
same day. On hospital day 2, he developed a fever (38.2°C) and
leukocytosis (white blood cell count, 11.5  109/liter), with
89% of the cells being polymorphonuclear leukocytes, and the
C-reactive protein (CRP) level was 128 mg/liter. Three sets of
blood samples and a wound swab were obtained for cultures,
which were negative for growth. After the first operation, the
patient suffered from rhabdomyolysis and compartment syn-
drome. Consequently, an above-the-knee amputation was per-
formed on day 3. One day after the second operation, his body
temperature suddenly further increased to 39.5°C, and three
sets of blood samples were drawn for additional cultures. After
one day of incubation in the BacT/Alert 3D blood culture
system (bioMe´rieux, Marcy l’Etoile, France), three aerobic and
two anaerobic culture bottles registered positive for bacterial
growth. Gram staining morphologies of the broths from the
aerobic and anaerobic culture bottles were identical, showing
Gram-negative bacilli. A single morphotype of medium-sized,
round, convex, and yellowish-brown-colored colonies on sheep
blood agar and small-sized, round, and colorless colonies on
MacConkey agar was obtained after subcultures from the three
aerobic bottles. All colonies showed identical triple sugar iron
reaction results of the alkaline slant-butt reactions and were
negative for gas and hydrogen sulfide production.
The Vitek 2 GN and ID 32 GN systems (bioMe´rieux) were
used for species identification. Both profiles were suggestive of
Pseudomonas putida (99.0% and 99.9% probabilities, respec-
tively). However, interestingly, the isolate grown on Mac-
Conkey agar showed a negative oxidase reaction, and colonies
on blood agar showed a weakly positive oxidase reaction. We
designated the isolate YMC09/4/B4619 by its specimen num-
ber, and we subjected it to 16S rRNA gene sequence analysis.
DNA was extracted using a DNeasy blood and tissue kit
(Qiagen GmbH, Hilden, Germany). The universal primers 8F
(5-AGA GTT TGA TCC TGG CTC AG-3) and 1541R (5-
AAG GAG GTG ATC CAG CCG CA-3) were used to am-
plify a 1,395-bp segment corresponding to part of the 16S
rRNA gene (6). The obtained sequence was compared with all
16S rRNA sequences available in the EMBL Nucleotide Se-
quence Database by using the FASTA program (http://www
.ebi.ac.uk/fasta33/). The highest sequence identity value of
99.7% (1,392/1,395 bp) was obtained with the strains of
Pseudomonas fulva (NRIC 0180T; GenBank accession number
AB060136). The next highest identity of 99.6% was obtained
with P. putida strains (NCB0308-456; GenBank accession number
AB294558). Additionally, we subjected it to gyrB, rpoB, and
rpoD gene sequence analyses. In brief, the designed primers
gyrb 2f (5-TCC GAG CAA CTG ATA CTG ACG-3), gyrb 2r
(5-GCC TTT ACG GCG AGT CAT CT-3), rpob 1f (5-TCA
AGG AAC GTC TGT CGA TG-3), rpob 1r (5-GTT CGG
GAT GTC TGC AGT G-3), rpod 1f (5-AGC TGC TGA
CCC GTG AAG-3), and rpod 1r (5-TTC CTT GAT TTC
GGA AAC G-3) were used to generate amplicons of each
gene sequence. Amplicons of 666 bp (gyrB), 1,034 bp (rpoB),
and 723 bp (rpoD) were produced. The sequences of the strain
YMC09/4/B4619 were found to be most closely related to
those of the type strains of P. fulva; identity was 92.5% with
strain IAM 1529T (GenBank accession number AB039395) for
gyrB gene, 97.2% with strain CIP 106765T (GenBank accession
number AJ717419) for rpoB gene, and 96.5% with strain IAM
1529 (GenBank accession number AB039586) for rpoD gene.
The identities with P. putida strains were 89.1% with strain
ATCC17485, 93.4% with strain KT2440, and 89.1% with strain
ATCC17485 for gyrB, rpoB, and rpoD genes, respectively.
Physiological and biochemical characteristics of the strain
YMC09/4/B4619 were determined using conventional methods
and miniaturized identification systems. Production of pyocy-
anin and formation of fluorescent pigments were tested on
Pseudomonas agar P and Pseudomonas agar F (Difco Labora-
tories, Detroit, MI), respectively. The motility test results, ox-
idase and catalase reactions, test results for indole, and hydro-
lysis of starch were determined. The growth at 4 and 41°C was
determined on Mueller-Hinton agar (BBL, BD Diagnostics,
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Sparks, MD) (1). Vitek 2 GN, ID 32 GN, and API 20NE
systems (bioMe´rieux) were used to test biochemical properties
according to the manufacturer’s instructions. Phenotypic char-
acteristics are displayed in Table S1 in the supplemental ma-
terial. It was motile and positive for production of yellow-
orange pigments, catalase production, arginine dihydrolase,
and growth at 4°C. The strain utilized D-glucose, D-mannose,
gluconate, malate, and citrate. It was negative for the produc-
tion of fluorescent pigment and pyocyanin, hydrolysis of gelatin
and starch, nitrate reduction, growth at 41°C, and utilization of
maltose, sucrose, D-mannitol, malonate, and m-hydroxyben-
zoic acid.
Phylogenetic trees were constructed to confirm the species
not only from the data of the 16S rRNA (8) but also from the
combined nucleotide sequences of the gyrB and rpoD genes,
with the assumption that longer sequences would result in
better reliability (9). The phylogenetic trees revealed that the
strain YMC09/4/B4619 had the highest sequence similarity to
P. fulva sequences (see Fig. S1 in the supplemental material).
Antimicrobial susceptibility of the organism was determined
using Etest (AB Biodisk, Solna, Sweden) according to the
manufacturer’s instruction. The antibiotic susceptibility pat-
terns were interpreted according to Clinical and Laboratory
Standards Institute standards (2). The organism was resistant
to chloramphenicol and trimethoprim-sulfamethoxazole and
was susceptible to piperacillin-tazobactam, ceftazidime, cefo-
taxime, aztreonam, cefepime, imipenem, meropenem, genta-
micin, tobramycin, amikacin, and levofloxacin.
The patient was treated with piperacillin-tazobactam and
clindamycin after his fever spiked on day 4. His body temper-
ature decreased to 37°C on day 6. Follow-up blood cultures
were requested on day 7, and results thereafter were negative
for growth. Four environmental cultures of soil and instru-
ments from the accident site were performed, but they showed
no organism growth. The patient was discharged on day 76
after he underwent rehabilitation training.
Pseudomonas fulva was isolated for the first time from Jap-
anese rice paddies in 1963 (8). It has not yet been isolated from
humans as an infectious agent, and its association with human
infections was otherwise unknown. This is the first report in
which P. fulva has been isolated from human blood samples.
Pseudomonas fulva shares phenotypic characteristics with
members of the fluorescent Pseudomonas group, particularly
P. putida, but possesses some unique features. Most remark-
ably, P. fulva produces yellow pigments, whereas it does not
produce fluorescent pigment, unlike P. putida. And P. fulva
does not assimilate malonate and m-hydroxybenzoate, whereas
P. putida does. It is also different from Pseudomonas aeruginosa
in its inability for growing at 41°C, reducing nitrate, hydrolysis
of gelatin, and utilization of D-mannitol (7, 8) (see Table S1 in
the supplemental material). Uniquely, its oxidase reaction is
weakly positive and may be negative when taken from the
surface of a differential medium, such as MacConkey agar, due
to acidification resulting from the fermentation of carbohy-
drates (4). Some authors report that 16S rRNA gene se-
quences are too conservative to determine inter- and intrage-
neric relationships in closely related bacterial species (3).
Notably, the gyrB gene has been reported to be a more reliable
PCR target than the 16S rRNA sequences for detection of P.
aeruginosa (5). However, in this case, identification of the iso-
late was confirmed by the congruent results of genetic analyses
of the 16S rRNA, gyrB, rpoB, and rpoD gene sequences. The
anaerobic broth was not cultured because the Gram stain mor-
phologies of both the aerobic and anaerobic culture bottles
were identical. Nonetheless, anaerobes might be involved in
this infection.
Pseudomonas fulva is isolated mainly from environmental
sources. Although environmental cultures from the accident
field were negative, we hypothesize that the bacteria likely
entered the bloodstream through the wound inflicted at the
construction site. We believe that from now on P. fulva should
be considered another potential microorganism of trauma-
related bloodstream infections in humans.
Nucleotide sequence accession numbers. The nucleotide se-
quence data of the strain YMC09/4/B4619 have been assigned
EMBL/GenBank nucleotide accession numbers FN599522,
FN599523, FN599524, and FN599525 for the 16S rRNA, gyrB,
rpoB, and rpoD genes, respectively.
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